Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value ($000): $2,014,483 (100.0% shares, 0.0% debt)

Holdings (42)

VTI VANGUARD INDEX FDS 26.0%
Value ($000) $522,920 Shares 3,070,400 Est. Cost $154.84 Unrealized
AAPL APPLE INC 7.2%
Value ($000) $145,006 Shares 1,252,104 Est. Cost $90.57 Unrealized +17.0%
CATALENT INC 6.9%
Value ($000) $139,283 Shares 1,626,000 Est. Cost $79.39 Unrealized
HRMY HARMONY BIOSCIENCES HLDGS IN 6.3%
Value ($000) $127,294 Shares 3,754,973 Est. Cost $36.46 Unrealized 0.0%
CABO CABLE ONE INC 5.4%
Value ($000) $108,018 Shares 57,291 Est. Cost $1045.88 Unrealized +60.6%
INGN INOGEN INC 5.1%
Value ($000) $102,930 Shares 3,549,320 Est. Cost $17.78 Unrealized +76.7%
MDT MEDTRONIC PLC 5.1%
Value ($000) $102,687 Shares 988,136 Est. Cost $81.79 Unrealized +5.4%
BROOKFIELD ASSET MGMT INC 5.0%
Value ($000) $101,526 Shares 3,070,957 Est. Cost $36.83 Unrealized
NKTX NKARTA INC 4.2%
Value ($000) $83,984 Shares 2,793,864 Est. Cost $29.47 Unrealized 0.0%
MORPHIC HLDG INC 3.6%
Value ($000) $72,326 Shares 2,645,446 Est. Cost $19.82 Unrealized
INOZYME PHARMA INC 3.4%
Value ($000) $67,549 Shares 2,569,379 Est. Cost $26.29 Unrealized
MIRM MIRUM PHARMACEUTICALS INC 2.3%
Value ($000) $47,118 Shares 2,445,147 Est. Cost $12.27 Unrealized +75.0%
FOLD AMICUS THERAPEUTICS INC 1.6%
Value ($000) $32,759 Shares 2,320,026 Est. Cost $13.98 Unrealized +4.3%
PCVX VAXCYTE INC 1.6%
Value ($000) $32,159 Shares 651,255 Est. Cost $32.16 Unrealized +23.8%
GRTX GALERA THERAPEUTICS INC 1.5%
Value ($000) $30,818 Shares 3,409,021 Est. Cost $12.19 Unrealized -35.0%
CHECKMATE PHARMACEUTICALS IN 1.2%
Value ($000) $24,978 Shares 2,170,100 Est. Cost $11.51 Unrealized
SEASPINE HLDGS CORP 1.2%
Value ($000) $23,988 Shares 1,677,492 Est. Cost $11.34 Unrealized
BLUEPRINT MEDICINES CORP 1.1%
Value ($000) $21,783 Shares 234,979 Est. Cost $77.20 Unrealized
SIBN SI BONE INC 0.8%
Value ($000) $16,569 Shares 698,504 Est. Cost $18.82 Unrealized +5.6%
PTGX PROTAGONIST THERAPEUTICS INC 0.8%
Value ($000) $15,530 Shares 794,369 Est. Cost $11.19 Unrealized +67.7%
MIST MILESTONE PHARMACEUTICALS IN 0.8%
Value ($000) $15,230 Shares 2,080,585 Est. Cost $20.62 Unrealized -65.2%
FLEXION THERAPEUTICS INC 0.7%
Value ($000) $14,609 Shares 1,403,370 Est. Cost $13.15 Unrealized
INSM INSMED INC 0.7%
Value ($000) $13,824 Shares 430,107 Est. Cost $23.71 Unrealized +21.2%
IOVA IOVANCE BIOTHERAPEUTICS INC 0.6%
Value ($000) $12,672 Shares 384,938 Est. Cost $30.66 Unrealized 0.0%
CONSTELLATION PHARMCETICLS I 0.6%
Value ($000) $11,713 Shares 578,134 Est. Cost $28.06 Unrealized
VERONA PHARMA PLC 0.6%
Value ($000) $11,237 Shares 1,800,747 Est. Cost $8.47 Unrealized
AKOUOS INC 0.5%
Value ($000) $10,488 Shares 458,606 Est. Cost $22.50 Unrealized
SPRO SPERO THERAPEUTICS INC 0.5%
Value ($000) $10,391 Shares 931,099 Est. Cost $11.41 Unrealized +3.7%
FREELINE THERAPEUTICS HLDGS 0.5%
Value ($000) $10,381 Shares 665,000 Est. Cost $15.61 Unrealized
AERIE PHARMACEUTICALS INC 0.5%
Value ($000) $9,506 Shares 807,656 Est. Cost $43.09 Unrealized
CUREVAC N V 0.5%
Value ($000) $9,386 Shares 201,642 Est. Cost $46.55 Unrealized
SILK RD MED INC 0.4%
Value ($000) $8,430 Shares 125,428 Est. Cost $41.96 Unrealized
INTERSECT ENT INC 0.4%
Value ($000) $8,375 Shares 513,515 Est. Cost $15.84 Unrealized
INSP INSPIRE MED SYS INC 0.4%
Value ($000) $7,697 Shares 59,645 Est. Cost $42.52 Unrealized +159.2%
AFIB ACUTUS MED INC 0.4%
Value ($000) $7,599 Shares 255,000 Est. Cost $30.36 Unrealized 0.0%
ZOGENIX INC 0.3%
Value ($000) $5,842 Shares 325,814 Est. Cost $27.12 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 0.3%
Value ($000) $5,572 Shares 1,389,498 Est. Cost $13.03 Unrealized -69.3%
BIOHAVEN PHARMACTL HLDG CO L 0.3%
Value ($000) $5,500 Shares 84,600 Est. Cost $51.38 Unrealized
INARI MED INC 0.3%
Value ($000) $5,211 Shares 75,500 Est. Cost $48.44 Unrealized
AKBA AKEBIA THERAPEUTICS INC 0.2%
Value ($000) $4,989 Shares 1,987,506 Est. Cost $11.95 Unrealized -26.5%
CRNX CRINETICS PHARMACEUTICALS IN 0.2%
Value ($000) $4,252 Shares 271,378 Est. Cost $23.34 Unrealized -34.5%
ENTASIS THERAPEUTICS HLDGS I 0.1%
Value ($000) $2,354 Shares 1,153,911 Est. Cost $10.88 Unrealized